DelMar Pharmaceuticals initiates Phase 2 clinical trial in newly diagnosed MGMT-unmethylated GBM September 11, 2017 by True Academy Comments are off Posted in:Stock Market & Investment NewsTagged with:Buy Sell ShareFTSEKLCIMalaysiaPelaburanSahamShare Trading See more Prev:Deutsche Bank cautious on MGM Resorts Back: All Posts Next:Embraer mulls return to Chinese manufacturing